Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors
about
Gene Therapy for Pediatric Cancer: State of the Art and Future PerspectivesBioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approachVaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.In vivo cytokine gene transfer by gene gun reduces tumor growth in miceIL2 treatment for cancer: from biology to gene therapyLocal and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice.A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.Molecular characterization of defective antigen processing in human prostate cancer.Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gammaInterleukin 7 induces CD4+ T cell-dependent tumor rejection.Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factorIn vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumorExpression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis.Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen.Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alphap53-independent apoptosis induced by paclitaxel through an indirect mechanism.Cancer immunotherapy: potential involvement of mediators.Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells.Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.Antitumor immunopreventive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo.Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells.Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.Transduction of the macrophage colony-stimulating factor gene into human multidrug resistant cancer cells: enhanced therapeutic efficacy of monoclonal anti-P-glycoprotein antibody in nude mice.Identifying tumor promoting genomic alterations in tumor-associated fibroblasts via retrovirus-insertional mutagenesis.Interferon-gamma-producing tumor induces host tumor-specific T cell responses.
P2860
Q24792778-4A8288BC-3232-4FD5-95C4-5983C26B7925Q33854375-2CD12C60-D5A2-4C8F-8F7C-280FAD32847EQ34183838-7A8C08E3-90E2-4446-92BC-54A3A3386399Q34334817-17EB1B4C-C2C2-4BA3-9127-9549FEE31FA7Q34513704-69F51A64-52E8-4CBE-9CFC-03FBEC904919Q35565971-2A848589-9A52-41E9-838A-E366D8372110Q35796105-1D00A501-86A3-49CA-B69E-B5DCBD560001Q35976882-D6B60CBC-DB6D-4D98-9E10-5954751D574EQ35987503-08CF31CD-63B9-4ACD-A9C0-D047311D5206Q36183805-7334E131-5737-41D6-9012-BE835C11A765Q36199032-83F297E9-C2DB-40CA-AFDA-99A645587DA6Q36230708-A0578BD3-7D22-4838-873B-CBD3A324A5C7Q36238330-33EBF169-6417-43A3-8C5C-AA704DD64A4DQ36238339-8A18FE1C-3914-4A10-9D43-4E539A3F47A1Q36361923-FF30F328-0BAD-43E2-87A3-5CE41F065BE2Q36454472-AEA4BC5A-B098-4DD8-A56B-932A2169C1DFQ36470718-FC7E7161-AE1B-4786-AB1D-3446CFCB1369Q36573439-97FD7726-FF31-48BF-AEC3-595D9020813AQ36628188-282ABB6F-5332-4AE0-8132-7004B3123215Q36839708-D4AC102D-645F-4D24-8B8C-CEC5AAE6FEB9Q37599151-F86A705D-3E13-45F8-BF07-A8140DA4C14FQ40664478-9950FD50-BE48-488F-A512-A8BC33A2CCC2Q41482163-C683FBB0-F341-461A-9F1B-5184FB3C0765Q41892367-D3A89192-B308-4701-849D-A71EB1F66A2FQ41894129-D52E37E2-DA06-4530-980D-60256D3AB4CFQ45877340-FE8AEBE1-011D-4467-8ED4-51CD518ABAD1Q47144483-2DEE05B4-320B-493B-9AAB-7BC87F155249Q55423438-663EEA8F-D0F0-4D1F-8D24-1437E2A6A95E
P2860
Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Murine tumor cells transduced ...... necrosis factor against tumors
@ast
Murine tumor cells transduced ...... necrosis factor against tumors
@en
type
label
Murine tumor cells transduced ...... necrosis factor against tumors
@ast
Murine tumor cells transduced ...... necrosis factor against tumors
@en
prefLabel
Murine tumor cells transduced ...... necrosis factor against tumors
@ast
Murine tumor cells transduced ...... necrosis factor against tumors
@en
P2093
P2860
P1476
Murine tumor cells transduced ...... necrosis factor against tumors
@en
P2093
C M Reichert
M Kriegler
N P Restifo
S A Rosenberg
P2860
P304
P407
P577
1991-05-01T00:00:00Z